CD34 and leukemia: Likely, leukemia initiating ability in mouse models of CD34/CD38 defined sub-populations do not reflect clinical importance (see also next paragraph), since this ability is always assessed using purified populations, whereby the “competition” between these populations in outgrow and/or the relative therapy resistance cannot be taken into account.